phrykt

Johnson & Johnson (JNJ) net income: $26.8B

Johnson & Johnson reported a net income of $26.8B for the year ended Dec 28, 2025, up 90.6% from $14.1B a year earlier.

From Johnson & Johnson's filings with the SEC · Read the filing · JNJ stock page

Johnson & Johnson net income by year

$20.9B2021$17.9B2022$35.2B2023$14.1B2024$26.8B2025

#11 of 3,748 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 28, 2025$26.8B+91%
Dec 29, 2024$14.1B-60%
Dec 31, 2023$35.2B+96%
Jan 1, 2023$17.9B-14%
Jan 2, 2022$20.9B–

Net income of similar companies

Companies in the same industry as Johnson & Johnson, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
Johnson & Johnson$26.8BDec 28, 2025
Eli Lilly$20.6BDec 31, 2025
Merck$18.3BDec 31, 2025
Pfizer$7.8BDec 31, 2025
Bristol Myers Squibb$7.1BDec 31, 2025
Abbott Laboratories$6.5BDec 31, 2025
Regeneron Pharmaceuticals$4.5BDec 31, 2025

Questions and answers

What is Johnson & Johnson's net income?

Johnson & Johnson reported a net income of $26.8B for the year ended Dec 28, 2025, up 90.6% from $14.1B a year earlier.

Numbers as reported in Johnson & Johnson's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology